The FDA’s Pregnancy and Lactation Labeling Rule (PLLR) will replace conventional pregnancy letter categories with new data requirements to aid decision-makers in their assessment of pregnant or nursing mothers who require therapy. This descriptive study assessed the Crohn’s Disease (CD) population that may be impacted by new data from manufacturers to inform label updates.